摘要
简介:这项研究以社区为基础的墨西哥裔美国人样本中的血浆NfL与认知之间的关系为特征。 方法:544名参与者完成了一系列的神经心理学测试,并根据临床标准进行了诊断。 使用Simoa测定NfL。 跨组和测试的NfL水平进行了分析。 结果:正常和受损组之间存在NfL差异,这与整体认知,处理速度,执行功能和一系列学习任务相关,对所有诊断组均具有明显的负面影响。 NfL对正常和MCI组的处理速度,注意力,执行功能以及延迟记忆和识别记忆均具有负面影响。 结论:这项研究支持血浆NfL作为墨西哥裔美国人与神经退行性过程相关的认知障碍的标志物,并且可能是那些具有正常认知能力并有发展为MCI风险的人的早期认知变化的标志物。
关键词: 神经丝轻,墨西哥裔美国人,认知过程,正常认知,MCI,痴呆。
Current Alzheimer Research
Title:Relationship of Neurofilament Light (NfL) and Cognitive Performance in a Sample of Mexican Americans with Normal Cognition, Mild Cognitive Impairment and Dementia
Volume: 17 Issue: 13
关键词: 神经丝轻,墨西哥裔美国人,认知过程,正常认知,MCI,痴呆。
摘要:
Introduction: This study characterized the relationship between plasma NfL and cognition in a community-based sample of older Mexican Americans.
Methods: 544 participants completed a battery of neuropsychological tests and were diagnosed using clinical criteria. NfL was assayed using Simoa. NfL levels across groups and tests were analyzed.
Results: Difference in NfL was found between normal and impaired groups and was related to global cognition, processing speed, executive functions and a list of learning tasks with a significant negative effect for all diagnostic groups. NfL had a negative impact on processing speed, attention, executive functions and delayed and recognition memory for both normal and MCI groups.
Conclusion: The research supports plasma NfL as a marker of cognitive impairment related to neurodegenerative processes in Mexican Americans and may be a marker of early changes in cognition in those with normal cognition and at risk for developing MCI.
Export Options
About this article
Cite this article as:
Relationship of Neurofilament Light (NfL) and Cognitive Performance in a Sample of Mexican Americans with Normal Cognition, Mild Cognitive Impairment and Dementia, Current Alzheimer Research 2020; 17 (13) . https://dx.doi.org/10.2174/1567205018666210219105949
DOI https://dx.doi.org/10.2174/1567205018666210219105949 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Nanotechnologies: A Strategy to Overcome Blood-Brain Barrier
Current Drug Metabolism HIV-1 gp120 and Drugs of Abuse: Interactions in the Central Nervous System
Current HIV Research Hypertensive Pharmacogenomics in African Americans
Current Pharmacogenomics Synaptic Plasticity, Dementia and Alzheimer Disease
CNS & Neurological Disorders - Drug Targets Voluntary Running and Environmental Enrichment Restores Impaired Hippocampal Neurogenesis in a Triple Transgenic Mouse Model of Alzheimers Disease
Current Alzheimer Research Effects of Exercise and Ferulic Acid on Alpha Synuclein and Neuroprotective Heat Shock Protein 70 in An Experimental Model of Parkinsonism Disease
CNS & Neurological Disorders - Drug Targets Cannabinoids and Parkinsons Disease
CNS & Neurological Disorders - Drug Targets Bioactivities of Iridoids
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Cognitive Consequences of a Sustained Monocyte Type 1 IFN Response in HIV-1 Infection
Current HIV Research Covid-19 in Man: A Very Dangerous Affair
Endocrine, Metabolic & Immune Disorders - Drug Targets Blockers of Voltage-Gated Sodium Channels for the Treatment of Central Nervous System Diseases
Recent Patents on CNS Drug Discovery (Discontinued) Cognitive Impairment in Systemic Lupus Erythematosus: Prevalence and Clinical Importance
Current Rheumatology Reviews BELFAST Centenarians: A Case of Optimal Cardiovascular Risk?
Current Pharmaceutical Design The Cerebrospinal Fluid Amyloid β42/40 Ratio in the Differentiation of Alzheimers Disease from Non-Alzheimers Dementia
Current Alzheimer Research Stroke and Hypertension: An Appraisal from Pathophysiology to Clinical Practice
Current Vascular Pharmacology Bromelain Degrades Aβ1-42 Monomers and Soluble Aggregates: An In Vitro Study in Cerebrospinal Fluid of Alzheimer’s Disease Patients
Current Alzheimer Research Therapeutic Approaches to the Challenge of Neuronal Ceroid Lipofuscinoses
Current Pharmaceutical Biotechnology Modulation of Monoaminergic Transporters by Choline-Containing Phospholipids in Rat Brain
CNS & Neurological Disorders - Drug Targets Quinoline: An Attractive Scaffold in Drug Design
Mini-Reviews in Medicinal Chemistry Directions for Enhancement of the Therapeutic Efficacy of Mesenchymal Stem Cells in Different Neurodegenerative and Cardiovascular Diseases: Current Status and Future Perspectives
Current Stem Cell Research & Therapy